Thermo Fisher Scientific, Inc. Stock
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 609.71 USD | -1.48% |
|
+0.00% | +5.48% |
| 03:07am | Nvidia, Lilly Launching AI Lab for Drug Discovery Projects | MT |
| 02:42am | Nvidia, Eli Lilly to Launch AI-Powered Co-Innovation Lab -- Update | DJ |
| Capitalization | 233B 199B 185B 173B 323B 20,956B 346B 2,133B 838B 10,025B 872B 854B 36,759B | P/E ratio 2025 * |
34.7x | P/E ratio 2026 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise value | 261B 223B 208B 194B 362B 23,505B 388B 2,392B 940B 11,245B 978B 958B 41,231B | EV / Sales 2025 * |
5.89x | EV / Sales 2026 * | 5.51x |
| Free-Float |
86.06% | Yield 2025 * |
0.27% | Yield 2026 * | 0.28% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | -1.48% | ||
| 1 week | +0.00% | ||
| Current month | +5.48% | ||
| 1 month | +6.81% | ||
| 3 months | +16.52% | ||
| 6 months | +43.70% | ||
| Current year | +5.48% |
| 1 week | 603.99 |  | 628.08 |
| 1 month | 554.53 | | 628.08 |
| Current year | 577 | | 628.08 |
| 1 year | 385.46 | | 628.08 |
| 3 years | 385.46 | | 628.08 |
| 5 years | 385.46 | | 672.34 |
| 10 years | 119.75 | | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 58 | 15/10/2009 |
| Director of Finance/CFO | 59 | 01/08/2015 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 68 | 09/11/2006 |
Marc Casper
CHM | Chairman | 58 | 26/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 65 | 26/05/2009 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.59% | 7.43% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.48% | +0.00% | +10.03% | +5.11% | 233B | |
| -3.00% | +0.60% | +5.56% | +121.75% | 208B | |
| -0.94% | +0.48% | -1.42% | -13.16% | 168B | |
| -2.25% | 0.00% | +0.92% | +104.41% | 145B | |
| +0.99% | +4.61% | -7.43% | -4.22% | 60.36B | |
| -2.40% | -1.22% | +16.95% | +6.93% | 49.4B | |
| -0.77% | +3.18% | +3.89% | -5.76% | 42.11B | |
| -1.48% | +1.01% | +0.63% | +30.84% | 39.76B | |
| -0.07% | +2.86% | +9.60% | +17.93% | 36.78B | |
| +0.98% | +6.95% | -11.83% | -37.28% | 35.3B | |
| Average | -1.09% | +3.87% | +2.69% | +22.65% | 101.72B | |
| Weighted average by Cap. | -1.58% | +3.93% | +3.83% | +39.13% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 44.28B 37.91B 35.26B 32.87B 61.42B 3,991B 65.88B 406B 160B 1,909B 166B 163B 7,000B | 46.57B 39.88B 37.08B 34.57B 64.6B 4,197B 69.29B 427B 168B 2,008B 175B 171B 7,362B |
| Net income | 6.72B 5.75B 5.35B 4.99B 9.32B 605B 9.99B 61.62B 24.22B 290B 25.19B 24.67B 1,062B | 7.39B 6.33B 5.88B 5.48B 10.25B 666B 10.99B 67.76B 26.64B 319B 27.7B 27.13B 1,168B |
| Net Debt | 28.29B 24.22B 22.53B 21B 39.24B 2,549B 42.09B 259B 102B 1,220B 106B 104B 4,472B | 23.96B 20.52B 19.08B 17.79B 33.24B 2,159B 35.65B 220B 86.39B 1,033B 89.85B 88.01B 3,788B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/01/26 | 611.62 $ | -1.17% | 1,349,126 |
| 09/01/26 | 618.86 $ | +2.04% | 2,286,520 |
| 08/01/26 | 606.50 $ | -1.73% | 3,147,727 |
| 07/01/26 | 617.15 $ | -0.58% | 2,404,599 |
| 06/01/26 | 620.72 $ | +1.56% | 2,554,872 |
Delayed Quote Nyse, 13 January 2026 at 04:27 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition